Technology
Health
Biotechnology

Navidea Biopharmaceuticals

$0.575
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.015 (-2.54%) As of 12:41 PM EDT today
-$0.015 (-2.54%) Today

Why Robinhood?

You can buy or sell NAVB and other stocks, options, ETFs, and crypto commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. Read More The company was founded in 1983 and is headquartered in Dublin, OH.

Employees
19
Headquarters
Dublin, Ohio
Founded
1983
Market Cap
5.93M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
814.72K
High Today
$0.59
Low Today
$0.5585
Open Price
$0.5899
Volume
100.93K
52 Week High
$2.84
52 Week Low
$0.1005

Collections

Technology
Health
Biotechnology
Therapy
US
North America

NAVB News

BenzingaJul 11

What Caused The Opening Gap In Navidea Biopharmaceuticals Stock?

295
Yahoo FinanceJun 13

Navidea Biopharmaceuticals Regains Direct Control of Intellectual Property

154

NAVB Earnings

-$0.24
-$0.17
-$0.09
-$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

More NAVB News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.